ANTIKREBSMITTEL

European patent · EP3676282 · In force

Register entry

Publication number
EP3676282
Application number
EP18868922
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 17, 2018
Published
Jul 8, 2020
Granted
Nov 6, 2024
Protection ends at the latest
Oct 16, 2038
Next annual fee due
Oct 31, 2026
IPC classes
C07K 7/06 (2006.01)
C07K 7/08 (2006.01)
C07F 9/74 (2006.01)
C07F 9/76 (2006.01)
C07F 9/78 (2006.01)
A61K 33/36 (2006.01)
A61K 47/64 (2017.01)
A61P 35/00 (2006.01)
G01N 33/574 (2006.01)
A61K 31/285 (2006.01)
A61K 45/06 (2006.01)
A61K 38/00 (2006.01)
Priority
AU 2017904199 17.10.2017
PCT application
PCT/AU2018/000202 17.10.2018
PCT publication
WO2019/075507 25.04.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Sep 17, 2025

    Change

    Published in Swissreg on 17.09.2025

  3. Jan 20, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 20.01.2025

  4. Nov 6, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.11.2024

Parties

Holder

University of Wollongong

Northfields Avenue, New South Wales 2522, AU

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

DILLON, Carolyn Therese

Wollongong, NSW 2500, AU

CARRALL, Judith Anne

Wollongong, NSW 2500, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.